EphA4 activation mediates synaptic damage in AD (Vargas et al., 2014; Zhao et al., 2018) and its inhibition rescues neurodegeneration in amyotrophic lateral sclerosis (ALS; Faruqi, 2012; Van Hoecke et al., 2012). The gene discussed is EPHA4; the disease is Alzheimer disease.